A systematic comparison of microsimulation models of colorectal cancer: The role of assumptions about adenoma progression

Medical Decision Making

Volumn 31, Issue 4, 2011, Pages 530-539

  Kuntz, Karen M ^a   Lansdorp Vogelaar, Iris ^b   Rutter, Carolyn M ^c   Knudsen, Amy B ^d   Van Ballegooijen, Marjolein ^a   Savarino, James E ^c   Feuer, Eric J ^e   Zauber, Ann G ^f  

^a UNIVERSITY OF MINNESOTA   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c GROUP HEALTH RESEARCH INSTITUTE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

colorectal cancer; microsimulation; screening

Indexed keywords

ADENOMA; AGED; ARTICLE; COLORECTAL TUMOR; COMPARATIVE STUDY; DISEASE COURSE; HUMAN; MIDDLE AGED; PATHOLOGY; THEORETICAL MODEL;

ADENOMA; AGED; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; HUMANS; MIDDLE AGED; MODELS, THEORETICAL;

EID: 79960532162     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X11408730     Document Type: Article

References (48)

1. Cancer Facts & Figures 2010. Atlanta, GA: American Cancer Society ; 2010 :
2. Morson BC. The pathogenesis of colorectal cancer: introduction. Major Probl Pathol. 1978 ; 10: 1-13
3. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008 ; 58: 130-60 (Pubitemid 351830299)
4. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008 ; 149: 627-37
5. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993 ; 328: 1365-71 (Pubitemid 23131388)
6. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999 ; 91: 434-7 (Pubitemid 29128279)
7. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996 ; 348: 1467-71 (Pubitemid 26400241)
8. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996 ; 348: 1472-7 (Pubitemid 26400242)
9. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000 ; 343: 1603-7 (Pubitemid 32162983)
10. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010 ; 375: 1624-33
11. Eddy DM, Nugent FW, Eddy JF, et al. Screening for colorectal cancer in a high-risk population: results of a mathematical model. Gastroenterology. 1987 ; 92: 682-92 (Pubitemid 17023731)
12. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA. 2000 ; 284: 1854-961
13. Glick S, Wagner JL, Johnson CD. Cost-effectiveness of double-contrast barium enema in screening for colorectal cancer. AJR Am J Roentgenol. 1998 ; 170: 629-36 (Pubitemid 28106650)
14. Joseph AM, Crowson TW, Rich EC. Cost effectiveness of HemoQuant versus Hemoccult for colorectal cancer screening. J Gen Intern Med. 1988 ; 3: 132-8
15. Khandker RK, Dulski JD, Kilpatrick JB, Ellis RP, Mitchell JB, Baine WB. A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults. Int J Technol Assess Health Care. 2000 ; 16: 799-810
16. Ladabaum U, Chopra CL, Huang G, Scheiman JM, Chernew ME, Fendrick AM. Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer: a cost-effectiveness analysis. Ann Intern Med. 2001 ; 135: 769-81 (Pubitemid 33051261)
17. Loeve F, Boer R, van Oortmarssen GJ, van Ballegooijen M, Habbema JD. The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening. Comput Biomed Res. 1999 ; 32: 13-33 (Pubitemid 29102594)
18. Ness RM, Holmes AM, Klein R, Dittus R. Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages. Am J Gastroenterol. 2000 ; 95: 1800-11 (Pubitemid 30485022)
19. Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med. 2000 ; 133: 573-84
20. Vijan S, Hwang EW, Hofer TP, Hayward RA. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Am J Med. 2001 ; 111: 593-601 (Pubitemid 34088068)
21. Wagner JL, Herdman RC, Wadhwa S. Cost effectiveness of colorectal cancer screening in the elderly. Ann Intern Med. 1991 ; 115: 807-17
22. Whynes DK. Cost-effectiveness of screening for colorectal cancer: evidence from the Nottingham faecal occult blood trial. J Med Screen. 2004 ; 11: 11-5 (Pubitemid 38365689)
23. National Cancer Policy Board Institute of Medicine. Curry S Byers T Hewitt M, ed. Washington, DC: National Academies Press ; 2003 :
24. Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2002 ; 137: 96-104 (Pubitemid 34779153)
25. Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary. Pignone M Russell L Wagner J, ed. Washington, DC: Institute of Medicine and National Research Council ; 2005 :
26. van Ballegooijen M, Rutter CM, Knudsen AB, et al. Clarifying differences in natural history between models of screening: the case of colorectal cancer. Med Decis Making. 2011 ; 31: 540-549
27. Noffsinger AE. Serrated polyps and colorectal cancer: new pathway to malignancy. Annu Rev Pathol Mech Dis. 2009 ; 4: 343-64
28. Clark JC, Collan Y, Eide TJ, et al. Prevalence of polyps in an autopsy series from areas with varying incidence of large-bowel cancer. Int J Cancer. 1985 ; 36: 179-86 (Pubitemid 15243443)
29. Blatt LJ. Polyps of the colon and rectum: incidence and distribution. Dis Colon Rectum. 1961 ; 4: 277-82
30. Arminski TC, McLean DW. Incidence and distribution of adenomatous polyps of the colon and rectum based on 1,000 autopsy examinations. Dis Colon Rectum. 1964 ; 7: 249-61
31. Vatn MH, Stalsberg H. The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer. 1982 ; 49: 819-25 (Pubitemid 12165443)
32. Jass JR, Young PJ, Robinson EM. Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas: a necropsy study in New Zealand. Gut. 1992 ; 33: 1508-14
33. Johannsen LGK, Momsen O, Jacobsen NO. Polyps of the large intestine in Aarhus, Demark: an autopsy study. Scand J Gastroenterol. 1989 ; 24: 799-806 (Pubitemid 19226933)
34. Bombi JA. Polyps of the colon in Barcelona, Spain. Cancer. 1988 ; 61: 1472-6
35. Williams AR, Balasooriya BAW, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut. 1982 ; 23: 835-42 (Pubitemid 12018511)
36. Rickert RR, Auerbach O, Garfinkel L, Hammond EC, Frasca JM. Adenomatous lesions of the large bowel: an autopsy survey. Cancer. 1979 ; 43: 1847-57 (Pubitemid 9203736)
37. Chapman I. Adenomatous polypi of large intestine: incidence and distribution. Ann Surg. 1963 ; 157: 223-6
38. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov), SEER*Stat Database: Incidence-SEER 9 Regs Public-Use, Nov 2003 Sub (1973-2001). Frederick, MD: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; 2004 (released April 2004, based on the November 2003 submission).
39. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997 ; 112: 594-642 (Pubitemid 27078848)
40. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med. 2002 ; 137: 129-31
41. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology. 2003 ; 124: 544-60 (Pubitemid 36169269)
42. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin. 2006 ; 56: 11-25 (Pubitemid 43228384)
43. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the US Preventive Services Task Force. Ann Intern Med. 2008 ; 149: 659-69
44. Lansdorp-Vogelaar I, Kuntz KM, Knudsen AB, Wilschut J, Zauber AG, van Ballegooijen M. Stool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysis. Ann Intern Med. 2010 ; 153: 368-77
45. Knudsen AB, Lansdorp-Vogelaar I, Rutter CM, et al. Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the Medicare population. J Natl Cancer Inst. 2010 ; 102: 1238-52
46. Hoff G, Grotmol T, Skovlund E, Bretthauer M. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ. 2009 ; 338: b1846
47. Segnan N, Senore C, Andreoni B, et al. Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy"- SCORE. J Natl Cancer Inst. 2002 ; 94: 1763-72 (Pubitemid 36007754)
48. Prorok PC, Andriole GL, Bresalier RS, et al. Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials. 2000 ; 21 (suppl 6). 273S - 309S